tirzepatide vs semaglutide clinical trials semaglutide: A new battle in obesity treatment Tirzepatide as Compared with Semaglutide
Description
Semagultide (GLP-1, GLP-1FDASemaglutide(
Semaglutide typically shows measurable weight loss within 4 to 8 weeks, with most patients experiencing steady progress through weeks 12 to 16
NEJM Editorial Fellow Harleen Marwah, MD, summarizes the SOUL trial
What If We've Been Asking the Wrong Question?Patients say compounded GLP-1s are more effective than branded medications
- Monitor blood sugar levels regularly as directed
